Microstimulation model identifies most cost-effective of 6 immune checkpoint inhibitor strategies for the first-line treatment of advanced renal cell carcinoma.
A retrospective study of Medicare data showed a potential factor in nonadherence to oral cancer treatment regimens.
Investigators concluded that there is minimal to no clinical value in surveillance for pulmonary recurrence after T1a RCC resection.
Researchers found preoperative blood glucose levels were associated with hospital length of stay for patients undergoing laparoscopic nephrectomy for RCC.
The approval was based on data from an open-label phase 2 study which evaluated the efficacy and safety of Welireg in patients with von Hippel-Lindau-associated renal cell carcinoma and other VHL-associated tumors.